Honolulu Mayor Signs Law Prohibiting Sale of Herbal Cigarettes

Regulations by 2FIRSTS.ai

Apr.17.2024

Honolulu Mayor Signs Law Prohibiting Sale of Herbal Cigarettes

Honolulu Mayor Rick Blangiardi signs Bill 1, prohibiting sale of herbal cigarettes to those under 21, addressing tobacco law loopholes.

According to a report by khon2 on April 16th, the Mayor of Honolulu, Rick Blangiardi, has signed Bill 1, which prohibits the sale of herbal cigarettes to individuals under the age of 21.

Lawmakers stated that the signing of the bill is to address loopholes in Hawaii's existing tobacco laws. Because herbal cigarettes do not contain tobacco or nicotine, individuals under the age of 21 can purchase such products.

State Assemblyman Tyler Dos Santos-Tam stated that the state government has been working to make it more difficult for young people to purchase e-cigarettes. "Youth advocates in our community are pushing for statewide legislation to ban the sale of flavored tobacco products aimed at our youth, and the recent 46th bill (2023) reinstates local control over tobacco products. This measure further demonstrates that the city is prepared to pass and enforce laws that protect our youth."

The first bill requires companies selling herbal cigarettes to display signage and inform consumers under the age of 21 of the prohibition.

References:

[1] New bill bans sale of herbal cigarettes to individuals under age of 21

Also Read:

[1] Hawaii County Proposes Ban on Flavored Tobacco Products

[2] Hawaii County Council Successfully Passes Bill to Ban Tobacco Imitations

#North America #United States #Traditional tobacco #Legislation #Regulation #Herbal cigarettes

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency

The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.

Dec.02 by 2FIRSTS.ai

Pakistan Speeds Up Local Nicotine Pouch Production as PMI Unit Prepares to Launch ZYN

Pakistan’s smokeless, tobacco-free nicotine pouch market has expanded rapidly in recent years, prompting major tobacco companies to accelerate local investments, with Philip Morris Pakistan Ltd. (PMPKL) set to produce ZYN at its Sahiwal facility.

Dec.05 by 2FIRSTS.ai

Philippine BIR Will Destroys Nearly 450,000 Illicit Vape Products Over Unpaid Taxes

The Philippine Bureau of Internal Revenue has led a nationwide destruction of illicit vape products, citing unpaid excise taxes and penalties amounting to 1.34 billion pesos(approximately US$22 million). Nearly 450,000 units are scheduled for destruction over three days across multiple revenue regions. The seized products violated excise tax laws due to non-payment of taxes, lack of internal revenue stamps, and non-registration of vape brands.

Dec.15 by 2FIRSTS.ai

Bangladesh High Court Questions Legality of BEZA’s Approval for Philip Morris Nicotine Pouch Factory

The High Court in Bangladesh has asked government bodies to explain why the approval granted to Philip Morris to establish a nicotine pouch factory should not be deemed illegal. Petitioners argue the decision contradicts existing policies and a 2016 Appellate Division ruling that restricts new tobacco-related enterprises. Authorities have ten days to respond.